All News

When Kathy LaTour learned about a group of people who had come together to advocate for cancer survivors, she joined their mission to spread awareness that the cancer experience still continues after treatment.

Survey results show that when one or more chronic condition was present physicians discussed trial participation with less than half of patients.

Izidore S. Lossos, M.D., discussed how questions remain on how to find the least toxic therapies that will prolong survival in both young and elderly patients with mantle cell lymphoma.

When the physical effects of cancer make it harder to do things, you can still find a way to move forward.

We all need to know how to take care of ourselves, succeed in balancing our lives, have quality of life and not feel guilty!

Previously treated patients with advanced small cell lung cancer (SCLC) benefitted from immunotherapy.

Regardless of the type of job you have, if you need to take time off work because of your cancer diagnosis and treatment, you should learn about your employment rights. Now the FMLA and the ADA can actually work together.

When someone is faced with a cancer diagnosis and treatment, they often wonder “do I need to go out on disability?” Unfortunately, they aren’t always sure what that actually means, or that it could mean multiple things.

In life, sometimes we are surprised beyond belief. There are three times in my life when having cancer made me think, "Wait! What?"

The Healing Net Foundation gathers patients, caregivers and health care providers to collaborate in raising awareness and educating the medical community about an underserved disease: neuroendocrine tumors.

Merger combines more than 30 years of patient-centered expertise to "Empower Everyone, Ignore No One."

Merger combines more than 30 years of patient-centered expertise to "Empower Everyone, Ignore No One."

A recent clinical trial is examining the combination regimen of netupitant plus palonosetron (NEPA), with hopes that it can curb nausea and vomiting both before and after chemotherapy in patients with peripheral T-cell lymphoma, Hodgkin lymphoma, mantle cell lymphoma and diffuse large B-cell lymphoma.

The expenses of cancer far extend what is covered by insurance, and the damage it can do can forever alter the life of a young adult with cancer.

An expert discusses how CAR-T cells will fit into the treatment paradigm for patients with multiple myeloma in the future.

Becoming a caregiving to a loved one with cancer feels as if my life has been turned upside down like a snow globe and I am left to hold on to the stable anchors.

In a follow-up post, one survivor explores the use of CBD products and shares how they've helped manage her post-cancer pain.

From today’s top entertainers and athletes to a ban on implants linked to cancer, here’s what is making headlines in the cancer space this week.

Although a reasonable and often curative treatment option, use of allogeneic hematopoietic stem cell therapy in relapsed multiple myeloma still tends to fall under the radar.

A model that calculates the probability of cancer may help to rule out a lung cancer diagnosis following screening preventions – which would substantially reduce false positives.

The FDA has expanded the approval of Ibrance (palbociclib) capsules in combination with endocrine therapy for male patients with hormone receptor (HR)–positive, HER2-negative advanced or metastatic breast cancer.

We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.

An expert discusses treating multiple myeloma with potential curative intent.

Create a digital health binder, improve communication, find clinical trials and get connected with three free mobile apps.

An expert discusses new treatment options for patients diagnosed with CLL.

Vice President Joe Biden discusses ways to work collectively with the Biden Cancer Initiative to explore gaps in cancer detection and treatment, identify solutions to address them and inject the urgency of now to make progress.

Patients speak up on the rarely discussed side effects of gynecologic cancers.

Patients with previously treated, advanced NSCLC who received Opdivo therapy experienced a survival benefit over many years, according to a pooled analysis of four studies.

This breast cancer and melanoma survivor encourages newly diagnosed cancer patients to hang onto their hope.

Patients with relapsed or refractory chronic lymphocytic leukemia may have more options now than ever before, according to William G. Wierda, M.D., Ph.D.